Pfizer rare heart disease drug reduces risk of death by 30 percent in study

[cafead]

via Pfizer Inc said on Monday that its drug tafamidis reduced the risk of death for patients with a rare and fatal heart disease by around 30 percent, boosting the prospects of what could be a billion-dollar-a-year drug.

article source

 

[anonymous]

via Pfizer Inc said on Monday that its drug tafamidis reduced the risk of death for patients with a rare and fatal heart disease by around 30 percent, boosting the prospects of what could be a billion-dollar-a-year drug.

article source

Don’t count your money yet, we’ve been here before.